Shares of Herbalife Nutrition Ltd. (NYSE:HLF – Get Rating) have been assigned a consensus recommendation of “Hold” from the eight ratings firms that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $36.80.
Several analysts have commented on the company. B. Riley cut their target price on Herbalife Nutrition from $50.00 to $41.00 in a research note on Wednesday. Jefferies Financial Group cut Herbalife Nutrition from a “buy” rating to a “hold” rating and lowered their price target for the company from $60.00 to $26.00 in a report on Wednesday. Zacks Investment Research cut Herbalife Nutrition from a “hold” rating to a “strong sell” rating in a report on Friday. Citigroup lowered their price target on Herbalife Nutrition from $46.00 to $36.00 in a report on Wednesday. Finally, StockNews.com raised Herbalife Nutrition from a “hold” rating to a “buy” rating in a report on Sunday, April 10th.
Shares of HLF opened at $24.41 on Friday. The business’s fifty day simple moving average is $30.84 and its two-hundred day simple moving average is $37.89. Herbalife Nutrition has a 12 month low of $23.75 and a 12 month high of $55.78. The company has a market cap of $2.65 billion, a price-to-earnings ratio of 6.54 and a beta of 1.07.
Herbalife Nutrition (NYSE:HLF – Get Rating) last issued its earnings results on Tuesday, May 3rd. The company reported $0.99 EPS for the quarter, beating the consensus estimate of $0.90 by $0.09. Herbalife Nutrition had a negative return on equity of 33.49% and a net margin of 7.06%. The business had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.38 billion. During the same period last year, the business posted $1.42 EPS. The company’s revenue was down 11.1% compared to the same quarter last year. Equities analysts expect that Herbalife Nutrition will post 3.83 earnings per share for the current fiscal year.
A number of institutional investors have recently made changes to their positions in HLF. Windacre Partnership LLC bought a new position in Herbalife Nutrition in the 4th quarter worth $109,087,000. Norges Bank bought a new position in Herbalife Nutrition in the 4th quarter worth $34,641,000. Deccan Value Investors L.P. raised its holdings in Herbalife Nutrition by 26.3% in the 3rd quarter. Deccan Value Investors L.P. now owns 3,745,293 shares of the company’s stock worth $158,726,000 after purchasing an additional 780,218 shares during the period. 683 Capital Management LLC raised its holdings in Herbalife Nutrition by 28.9% during the fourth quarter. 683 Capital Management LLC now owns 2,531,097 shares of the company’s stock valued at $103,597,000 after acquiring an additional 567,000 shares during the period. Finally, Bronte Capital Management Pty Ltd. raised its holdings in Herbalife Nutrition by 17.5% during the fourth quarter. Bronte Capital Management Pty Ltd. now owns 2,755,572 shares of the company’s stock valued at $112,786,000 after acquiring an additional 410,086 shares during the period.
About Herbalife Nutrition (Get Rating)
Herbalife Nutrition Ltd. offers nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and rest of Asia Pacific. The company provides products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition.
Receive News & Ratings for Herbalife Nutrition Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Herbalife Nutrition and related companies with MarketBeat.com’s FREE daily email newsletter.